Results 251 to 260 of about 932,790 (307)

The modified mRNA vaccine protects immunocompromised AG129 mice from lethal challenge and multi-tissue infection by Zika virus. [PDF]

Emerg Microbes Infect
Yan Y, Wang J, Yang H, Yang Y, Yuan L, Tang C, Zhou Y, Huang Q, Yu W, Liang X, Lin D, Li Y, Du X, Yuan Y, Peng R, Xu J, Guo Z, Xie W, Quan W, Chen H, Zhou J, Lu S, Peng X.   +22 more
europepmc   +1 more source

Meeting Summary for Keystone Symposia on HIV Cure: Antiretroviral Therapy (ART)-Free Control of HIV Infection in Durban, South Africa, 2025. [PDF]

Pathog Immun
Tanaka K, Chikowore TJB, Deeks SG, Estes JD, Ho YC, Jiang S, Lee MJ, Li C, Machinda A, Martins M, Mdletshe P, Ndhlovu ZM, Neogi U, Ott MM, Rasmussen TA, Reddy K, Rutishauser RL, Farrell-Sherman A, Tiemessen CT, Voss JE, Kityo C, Lewin SR, Ndung'u T, McCune JM.   +23 more
europepmc   +1 more source

Human metapneumovirus: understanding the molecular mechanisms and pathology of infection. [PDF]

J Virol
Heim CJ, van den Hoogen BG, Dutch RE.
europepmc   +1 more source

Patients with Trichinella spiralis infection display unmodified antigen-specific immune response to SARS-CoV-2. [PDF]

Mem Inst Oswaldo Cruz
Mitic I, Glamoclija S, Radulovic N, Sabljic L, Tomic S, Gruden-Movsesijan A, Sofronic-Milosavljevic L.   +6 more
europepmc   +1 more source

Structural and Mechanistic Basis for Antibody Neutralization of the Measles Fusion Protein

Zyla DS, Marca RD, Lacarbonara D, Niemeyer G, Zipursky G, Di Clemente L, Jonathan-Trakht G, Kalantarov G, Acciani M, Laterza G, Vyshenska D, Hastie KM, Horvat B, Greninger AL, Niewiesk S, Saphire EO, Porotto M.   +16 more
europepmc   +1 more source

Foot-and-mouth disease vaccine with insertion of a 24-amino acid VP1 G-H loop epitope of the Cathay virus provides broad antigenic coverage. [PDF]

Appl Microbiol Biotechnol
Zhang K, Zha J, Sun P, Ouyang Y, Zhang X, Ma X, Liu F, Li D, Bao H, Cao Y, Bai X, Fu Y, Li K, Yuan H, Zhang J, Zhao Z, Wang J, Zhang Q, Liu Z, Lu Z, Li P.   +20 more
europepmc   +1 more source

Human monoclonal antibodies to HPV16 show evidence for common developmental pathways and public epitopes. [PDF]

PLoS Pathog
Carter JJ, Hurlburt NK, Scherer EM, Singh S, Rodarte JV, Smith RA, Lewis P, Kinzelman R, Kieltyka J, Cabãn ME, Wipf GC, Pancera M, Galloway DA.   +12 more
europepmc   +1 more source

Versatile HIV Rev-dependent reporter cell system for stringent and sensitive quantification of viral reservoirs, neutralizing antibodies, and restriction factors

Spear M, Choi J, Hetrick B, Lee J, Lê-Bury G, Vo TT, Han Y, Liang H, Guo J, Yu D, Iyer S, Mwandumba HC, Russell DG, Wu Y, Gludish DW.   +14 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Histocompatibility Types and Viral Antibodies

Archives of Neurology, 1976
Serum neutralizing (Nt) antibodies to herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2), and histocompatibility (HL-A) types, were determined in multiple sclerosis (MS) patients and in control subjects. Titers of Nt antibodies to HSV-1 and to HSV-2 were increased among subjects bearing HL-A3 or HL-A7 or both, whether they suffered from MS or not ...
James R. Lehrich, Barry G. W. Arnason
openaire   +3 more sources